Capitalize on Pharmacokinetics Outsourcing Disruption as Charles River, Labcorp, WuXi AppTec, Eurofins and Sygnature Compete to Dominate Drug Development ROI
Demand for outsourced pharmacokinetics services is rising, driven by AI, advanced bioanalysis, personalized medicine, biologics and complex global trials. Demand for outsourced pharmacokinetics services is rising, driven by AI, advanced bioanalysis, personalized medicine, biologics and complex global trials.
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Europe SLI Battery Market to Reach US$11.7 Billion by 2031 Fueled by Start-Stop Vehicle Adoption and Rising Replacement Demand
- RobotPlusPlus Advances Industrial Maintenance with HighMate Series Demonstrated at SMM 2026
- LAMEA Automated and Closed Cell Therapy Processing Systems Market Outlook Report 2026-2033
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →